CJC-1295 (no DAC) — 5mg Research Vial
Modified GRF 1-29
$55.00
CJC-1295 (without DAC) is a modified GHRH analogue studied for its role in pulsatile growth hormone secretion in preclinical models. Frequently evaluated in combination with Ipamorelin in GH axis signaling research. Supplied as a lyophilized powder in a 3mL multi-dose vial. Purity ≥99% by HPLC. COA from an independent, accredited laboratory included. For research use only. Not for human consumption.
39 in stock
Download Certificate of Analysis (PDF)| Molecular weight | 3,367 Da |
|---|---|
| Sequence origin | Modified GHRH (1-29) analogue without Drug Affinity Complex |
| Primary pathways | GHRH-R (pituitary) |
| Solubility | Bacteriostatic water or sterile saline |
| Storage (lyophilized) | -20°C |
| Storage (in solution) | 4°C; use within 14 days of reconstitution |
| Preclinical research areas | Pulsatile GH secretion models, GH axis signaling studies, somatotroph cell biology |
For research use only. Not for human or veterinary use. Certificate of analysis available upon request.